Treatment of depersonalization with serotonin reuptake blockers
- PMID: 2115893
Treatment of depersonalization with serotonin reuptake blockers
Abstract
Eight patients with depersonalization disorder or with depersonalization symptoms in association with obsessive-compulsive and panic disorders were treated with serotonin reuptake blockers. There was clinical overlap of depersonalization disorder with obsessive-compulsive disorder, and the co-occurrence of obsessive-compulsive and panic features with depersonalization in these patients was associated with a favorable treatment outcome. The chronicity of illness and lack of prior response to a variety of treatments in these patients highlights the positive outcome with this treatment. In addition, issues are raised regarding the current hierarchical exclusion of depersonalization disorder in the presence of obsessive-compulsive and panic disorders.
Similar articles
-
Fenfluramine augmentation of serotonin reuptake blockade antiobsessional treatment.J Clin Psychiatry. 1990 Mar;51(3):119-23. J Clin Psychiatry. 1990. PMID: 2106515
-
[Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].Encephale. 1990 Jul-Aug;16 Spec No:359-62. Encephale. 1990. PMID: 2120029 French.
-
Obsessive-compulsive disorder.Am Fam Physician. 1989 May;39(5):175-82. Am Fam Physician. 1989. PMID: 2497627
-
A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.J Clin Psychiatry. 1990 Apr;51 Suppl:53-8; discussion 59-60. J Clin Psychiatry. 1990. PMID: 2139026 Review.
-
Serotonin and treatment in obsessive-compulsive disorder.Psychiatr Dev. 1989 Spring;7(1):1-18. Psychiatr Dev. 1989. PMID: 2508084 Review.
Cited by
-
Evidence-based treatment for Depersonalisation-derealisation Disorder (DPRD).BMC Psychol. 2013 Oct 28;1(1):20. doi: 10.1186/2050-7283-1-20. eCollection 2013. BMC Psychol. 2013. PMID: 25566370 Free PMC article.
-
The Potential Role of Naltrexone in Borderline Personality Disorder.Iran J Psychiatry. 2017 Apr;12(2):142-146. Iran J Psychiatry. 2017. PMID: 28659987 Free PMC article.
-
Safety and effectiveness of transcutaneous auricular vagus nerve stimulation on patients with depersonalization-derealization disorder: study protocol for a randomized controlled trial.Trials. 2024 Dec 5;25(1):812. doi: 10.1186/s13063-024-08658-w. Trials. 2024. PMID: 39639403 Free PMC article.
-
Depersonalisation disorder: a contemporary overview.CNS Drugs. 2004;18(6):343-54. doi: 10.2165/00023210-200418060-00002. CNS Drugs. 2004. PMID: 15089102 Review.
-
Transient depersonalisation/derealisation syndrome from tramadol.BMJ Case Rep. 2023 Jun 6;16(6):e254909. doi: 10.1136/bcr-2023-254909. BMJ Case Rep. 2023. PMID: 37280010 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical